mice, consistent with clinical macrocephaly. Adult Chd8 +/mice displayed normal social 33 interactions, and repetitive behaviors were not evident. Our results show that Chd8 +/mice 34 exhibit neurodevelopmental changes paralleling CHD8 +/humans and show that Chd8 is a global 35 genomic regulator of pathways disrupted in neurodevelopmental disorders. 36 37 relevant gene promoters and enhancers 12,14 . CHD8 DNA binding and knockdown studies in 61 human and mouse tissues and cells have revealed a multitude of genes directly and indirectly 62 activated or repressed by CHD8 during neurodevelopment 12,14 . 63
Summary

23
The chromatin remodeling gene CHD8 represents a central node in early neurodevelopmental 24 gene networks implicated in autism. We examined the impact of heterozygous germline Chd8 25 mutation on neurodevelopment in mice. Network analysis of neurodevelopmental gene 26 expression revealed subtle yet strongly significant widespread transcriptional changes in Chd8 +/-27 mice across autism-relevant networks from neurogenesis to synapse function. Chd8 +/expression 28 signatures included enrichment of RNA processing genes and a Chd8-regulated module featuring 29 altered transcription of chromatin remodeling, splicing, and cell cycle genes. Chd8 +/mice 30 exhibited increased proliferation during brain development and neonatal increase in cortical 31 length and volume. Structural MRI confirmed regional brain volume increase in adult Chd8 +/-32 Introduction 38 DNA packaging determines the transcriptional potential of a cell and is central to the 39 development and function of metazoan cell types. Chromatin remodeling complexes control 40 local chromatin state, yielding either transcriptional activation or repression. Pluripotency, 41 proliferation, and differentiation are dependent on genomic regulation at the chromatin level, and 42 proteins that control chromatin packaging are critical in development and cancer 1 . Although 43 many chromatin remodeling factors function across systems, case sequencing efforts have linked 44 mutations of chromatin genes with specific, causal roles in neurodevelopmental disorders 2-5 . This 45 finding is particularly strong for rare and de novo mutations in autism spectrum disorder 46 (ASD) 6, 7 . Understanding how mutations to chromatin remodeling genes affect transcriptional 47 regulation during brain development may reveal developmental and cellular mechanisms driving 48 neurodevelopmental disorders. 49
A key gene that has emerged from studies profiling rare and de novo coding variation in 50 ASD is the chromatin remodeler, CHD8 (Chromodomain helicase DNA binding protein 8) 8 . In 51 addition to ASD, CHD8 +/individuals exhibit macrocephaly, distinct craniofacial morphology, 52 mild-to-severe cognitive impairment, and gastrointestinal problems 8 . CHD8 mutation also has 53 been linked to attention deficit hyperactivity disorder, seizures, and schizophrenia 4,8 , as well as 54 cancer 9,10 . Homozygous deletion of Chd8 in mice is early embryonic lethal 11 . Chd8 knockdown 55 in zebrafish recapitulated macrocephaly and gastrointestinal phenotypes 8,12 , suggesting a high 56 degree of evolutionary conservation of Chd8 function in brain development. 57
Studies of genetic and protein networks have raised the possibility that CHD8 is a central 58 node and master regulator of early neurodevelopmental networks implicated in autism [12] [13] [14] . 59 CHD8 has been proposed to achieve this regulatory function in brain development by binding to 60 14.5 (E14.5), postnatal day 0 (P0), and adult mice (>P56) showed that heterozygous mutations to 83
Chd8 resulted in decreased Chd8 transcript and protein levels ( Figure 1D -1E, S1C; Chd8 84 antibody: ab114126, Abcam). For the majority of the following studies, we analyzed mice 85 qPCR showing reduction of RNA in Chd8 +/forebrain at P0 (n WT = 7, n Chd8 +/-= 5). E. Western blot of Chd8 +/mice showing reduction of Chd8 protein (ab114126; Abcam) in Chd8 +/forebrain at E14.5 (n WT = 9, Chd8 +/-= 9) and P0 (n WT = 4, Chd8 +/-= 3). F. Whole mount brain of Chd8 +/mice at P0 reveals increased cortical length, indicative of megalencephaly. OB: olfactory bulb, Cx: cortex, MB: midbrain, Cb: cerebellum. WT n male = 10, female = 4; Chd8 +/n male = 10, female = 4. G. (Upper) Representative coronal sections of wild-type and Chd8 +/brains at P7 visualized with Nissl, n = 4 for both genotypes. Scale bar 1000 µm. (Lower) Plots (mean ± SEM with dots representing individual samples) of cortical area, thickness at 30% and 70% distance from the dorsal midline, and cortical hemispheric circumference. P-values derived using Student's t-test for D, E and G and using ANOVA for F, *P < 0.05 ***P < 0.005 ****P < 0.001. harboring a 5 bp deletion in Chd8 exon 5. Male Chd8 +/mice were bred to wild-type females for 86 at least four generations before further experiments, and multiple litters were used for all 87 experiments to eliminate the potential impact of Cas9 off-target mutation. We tested for 88 differences in brain size in Chd8 +/mice at birth (postnatal day 0, P0), as macrocephaly is a 89 hallmark trait in human CHD8 +/individuals 8 . Maximal cortical anteroposterior length of Chd8 +/-90 brains was ~7% longer than matched wild-type (WT) littermates (ANOVA, p-value = 0.0440) 91 with no significant differences between sexes ( Figure 1F ). These results show that Chd8 +/mice 92 are megalencephalic, suggesting neuropathological phenotypes that parallel CHD8 +/humans. 93
To further test the parameters of developmental megalencephaly in Chd8 +/mutants, we 94 examined brains in whole-mount and Nissl-stained coronal brain sections at P7 ( Figure 1G ), a 95 time point after the conclusion of developmental neurogenesis and gliogenesis. At this stage, the 96 mutant brains did not present overt neuropathological anomalies other than size increase. Total 97 hemispheric circumference in Chd8 +/brains was 4.7% longer (Student's t-test, p = 0.0001) than 98 in WT littermates ( Figure 1G ). We measured cortical thickness in two positions across the 99 neocortex, at 30% and 70% distance from the dorsal midline. No significant differences between 100 the genotypes were observed in either location (Student's t-test, p = 0.2242; 0.2678), though 101
Chd8 +/mice trended larger across both measurements. Overall neocortical section area was ~8% 102 higher in Chd8 +/brains (Student's t-test, p = 0.0009) compared to WT controls, confirming 103 cerebral megalencephaly at this stage. 104
Differential gene expression across neurodevelopment in Chd8 +/mice 105
Having established neuroanatomical changes in Chd8 +/mice that parallel clinical 106 phenotypes described in CHD8 +/humans and considering the role of Chd8 in global 107 transcriptional regulation, we profiled mRNA utilizing RNA-sequencing in forebrain dissected 108 from four early developmental stages (embryonic days E12.5, E14.5, E17.5, and P0) and adult 109 mice (>P56) (Figure 2A ). After quality filtering, we individually analyzed 26 Chd8 +/and 18 WT 110 littermates, with full sample details reported in Table S1 . Sample developmental stage 111
represented the major components of gene expression variation, as expected given the large 112 Validation of DE expression of Tbr1 RNA (left; n WT = 7, Chd8 +/-= 5) and protein (right; n WT = 7, Chd8 +/-= 8) in Chd8 +/forebrain at P0 (Student's t-test, *P = 0.0264, 0.0338). G. Distribution of expected number of autism-associated genes among based on 100,000 randomly sampled gene sets (grey bars) versus observed number of autism-associated DE genes in our dataset (red bar). H. Comparison of DE down-and up-regulated genes identified here with autism-and Chd8-binding genes. Z-score generated via permutation test comparing enrichment of test gene set to randomly sampled genes. at lower frequency relative to WT allele reads, suggesting that the frameshift transcript 118 undergoes degradation ( Figure S1 ). 119 Using a statistical model that accounted for sex, developmental stage, and sequencing 120 batch, we tested for differential expression across 14,163 genes that were robustly expressed in 121 our datasets. At a significance cutoff corresponding to FDR < 0.05 (p-value < 0.0006), FDR < 122 0.1 (p-value < 0.0029) or FDR < 0.25 (p-value < 0.0272), 178, 418, and 1,536 genes, 123 respectively, were differentially expressed (DE) ( Table S2) . While our full model is best suited 124 for identification of genes where DE extends across developmental stages, we also examined 125 stage-specific expression changes and full results are reported in Table S2 . DE genes identified 126 in our full model exhibited a range of expression trajectories across development, and the 127 majority of significant expression changes in Chd8 +/were relatively small (99.3% < 1.0 absolute 128 log fold change, Figure 2B ). These findings suggest that changes in neurodevelopmental gene 129 expression are widespread yet subtle. We validated change in expression at P0 for a set of DE 130 changes in Chd8 expression were present in the Chd8 +/mice based on exon coverage ( Figure  136 S3). DE genes were significantly overrepresented among a number of Reactome 15 pathways 137 (Table S4 ). Example pathways with strong enrichment include RNA processing (e.g. Processing 138
of Capped Intron-Containing Pre-mRNA, FDR = 1.59E-09), gene expression (FDR = 1.66E-04), 139 cell cycle (FDR = 0.002), Regulation of TP53 Activity (FDR = 0.009), and Axon Guidance 140 (FDR = 0.009). Similar overall pathway enrichment was observed for DE genes at FDR cutoff of 141 0.05, 0.1, and 0.25. The strong signature of differential expression enabled us to map the 142 perturbation of biological pathways and processes caused by Chd8 haploinsufficiency across 143 neurodevelopment. 144
Overlap of autism-relevant genes and Chd8 binding targets with Chd8 +/-DE genes 145
First we examined whether Chd8 acts as a regulator of autism-linked genes during brain 146 development. In agreement with previous in vitro knockdown models 12,14 , autism risk genes were 147 among DE genes in Chd8 +/-. Figure 2D shows example DE high-confidence autism risk loci 148 (Kdm5b, Bcl11a, and Tbr1) with different developmental expression patterns. We validated 149 decrease in mRNA expression and protein level for Tbr1 at P0 in Chd8 +/forebrain via qPCR 150 analysis and western blot ( Figure 2E , Figure S4 ). We next tested for overlap between DE down-151 regulated and up-regulated genes (FDR < 0.25) and published gene sets of relevance to autism 152 genetics and Chd8 regulation. For example, of the 143 genes implicated by presence of 153 mutations in autism cases 16 that were detected in our expression data, 24 were DE at FDR < 0.25 154 and down-regulated (permutation test p-value = 3.08E−07) ( Figure 2F ). We also observed 155 significant enrichment among down-regulated DE genes with autism risk genes identified by 156 other studies 13, 17 ( Figure 2G ). We examined global gene co-expression networks relevant to 157 autism as identified via network analysis of human neurodevelopmental gene expression 18 , 158 global enrichment among DE down-regulated genes for the later developmental modules or 164 among FMRP targets 19 and gene networks identified in postmortem autism case brains 20 . 165
Next we asked whether our DE data is consistent with CHD8 binding and differential 166 expression after CHD8 knockdown in human in vitro models, as reported in previous studies 12, 14 . 167
While these studies show that CHD8 directly regulates a large number of promoters across 168 mouse and human systems, we nonetheless observed consistent enrichment among down-169 regulated DE genes in Chd8 +/forebrain for CHD8 target genes identified in these earlier studies 170 ( Figure 2G ). For example, down-regulated DE genes from our study were enriched for genes 171 with Chd8 promoter binding in E17.5 mouse frontal or occipital cortex 14 (p-value = 4.70E-29). 172
There was no enrichment among our up-regulated DE sets for genes targeted by CHD8, 173
suggesting that up-regulation is indirect or occurs at earlier time points. Comparing DE genes 174 that exhibited down-or up-regulation in our study with genes that show DE in the matched 175 direction in the independent knockdown studies discussed above, we observed strong direction-176 specific enrichment between our study and these two previous studies ( Figure 2G ). 177
Finally, we see that differential expression is not limited to early developmental effects. 178 For example, many synaptic genes are also impacted ( Figure S5 ). Consistent with previous 179 studies, we observed that Chd8 regulates TP53 and, to a lesser degree, Wnt signaling pathways 180 that control processes from early neurodevelopment to synaptic function 10,21,22 . As such, CHD8 181 expression trajectories during brain development with a goal of identifying stage-specific 187 neurodevelopmental processes that are perturbed in Chd8 +/mice. We used weighted gene 188 correlation network analysis (WGCNA 23 ) to identify co-regulated gene modules from our 189 developmental transcriptomic data. Fifteen discrete modules were identified that exhibited 190 specific trajectories of expression and covariation across forebrain development ( Figure 3A -3B, 191 Figure S6 , Table S5 ). DE genes assigned to specific modules were enriched for relevant gene 192 sets ( Figure 3C ) and stage-specific Gene Ontology Biological Process annotation terms ( Figure  193 3D, Table S7 ), confirming that the modules captured by this approach are developmentally and 194 biologically relevant. 195
First, we looked at module representation among high-confidence autism genes identified 196 in autism genome sequencing efforts 16 . While these genes were strongly enriched overall among 197 DE down-regulated genes ( Figure 2F and synapse function, the three major pathological pathways implicated via human genetics 6 . 216
In contrast to the spread of high confidence autism risk genes across developmental 217 modules, we observed strong module-specific enrichment for autism-associated developmental 218 expression networks identified by Parikshak et al. 2013 , as well as for CHD8 binding and 219 knockdown data, and DE genes whose transcripts are FMRP targets (Table S6) . To illustrate this, 220
we highlighted gene set enrichment for down-regulated DE genes from three modules with 221 distinct developmental trajectories discussed above, M.1, M.4, and M.2 ( Figure 3C ). We 222 observed enrichment in overlap with genes in Parikshak Finally, we found module-specific enrichment of genes down-regulated after CHD8 knockdown 233 in hNSC (M.1) and hNPC (M.4), suggesting similar gene regulatory consequences produced by 234
Chd8 haploinsufficiency across systems. 235
Chd8 +/mice exhibit down-regulation of genes involved in RNA processing in forebrain across 236 developmental expression modules 237
A number of GO terms were strongly enriched for DE genes mapping across modules, 238 suggesting perturbation to stage-specific gene sets controlling these processes across 239 developmental stages ( Figure 3D ). This signature was particularly strong for genes involved in 240 RNA processing ( Figure 4 ). DE genes were significantly overrepresented among genes annotated 241 to RNA processing, e.g. Processing of Capped Intron-Containing pre-mRNA (FDR = 1.59E-09), 242
mRNA Splicing (FDR = 2.90E-09), and mRNA 3'-end Processing (FDR = 3.29E-04) in the 243 Reactome database ( Figure 4A , Table S4 ). These genes represented modules with highly 244 divergent expression trajectories ( Figure 4B ). For example, among genes annotated to RNA 245 splicing, expression of Dhx9 (M.1) decreases across neurodevelopment and has not been 246 functionally characterized in brain but has been reported in autism-risk networks 17 ( Figure 4B ), 247
while Upf3b (M.15) expression increases across development and is a neuron-specific factor 248 required during neuronal differentiation that is implicated in intellectual disability 24,25 ( Figure  249 4B). While RNA processing genes present different overall expression trajectories across brain 250 development, perturbation to expression generally peaked at E17.5 for these genes, suggesting 251 that this represents a period where this process is critical in brain development. Unlike synaptic 252 genes and critical transcription factor genes (e.g. Tbr1), the DE genes annotated to have a role in 253 RNA processing have not been well studied in the context of brain development and represent 254 candidates for future investigation. RNA processing genes that are DE in Chd8 +/mice are 255 reported in Table S8 . 256 genome structure, cellular proliferation and differentiation, with enrichment for GO terms ( Table  270 S9) including RNA processing, chromatin organization, and mitotic cell cycle ( Figure 5C ). M.1 271 DE genes annotated to these terms, including a number of autism risk genes, were identified as 272
Perturbation to early developmental expression network and associated increase in neuronal
Chd8 targets. A subset of these genes was also DE after CHD8 in vitro knockdown in human 273 cells ( Figure 4D ). This analysis suggests that Chd8 binding directly regulates M.1 genes and that 274 differential expression of M.1 genes in Chd8 +/embryos may drive changes in chromatin 275 structure and RNA metabolism linked to early neurodevelopmental pathology associated with 276 disruption to proliferation and neuronal differentiation. 277
To examine whether these alterations in developmental genes play a functional role in 278 neuronal development that could lead to megalencephaly, we performed 5-ethynyl-2′-279 deoxyuridine (EdU) proliferation assays ( Figure 5E ). Assessing the number of EdU + cells in the 280 cortical ventricular zone (VZ) after a 1.5 hour pulse at E13.5, a time point of peak neurogenesis, 281
we found their number significantly increased in the mutant by 15.9% (Student's t-test, p = 282 0.0338, n = 4 for either genotype). Considering that a number of genes associated with brain 283 development and cortical structure exhibited DE, we also examined cortical morphology via 284 analysis of Tbr1 and Ctip2 immunostaining at P0 ( Figure S7 ). We observed no gross alterations 285 to lamination and found no evidence for focal cortical lesions (n: WT = 8; Chd8 +/-= 10). These 286 findings experimentally corroborate altered proliferative dynamics in Chd8 +/mutants, linking 287 altered neurogenesis and megalencephaly in Chd8 +/mice. 288
Analysis of Chd8 +/adult brain structure via MRI 289
To establish whether structural changes persist in the Chd8 +/mouse brain, structural MRI 290 was performed to identify changes in regional brain volume and connectivity between adult 291
Chd8 +/mice (n=18) and matched wild-type littermates (n=21). No significant differences were 292 observed in body weight or other relevant measures of general health in adult Chd8 +/mice 293 (Table S10 ). Neuroanatomy was assessed and volume was measured as absolute volume (mm 3 ) 294 and relative volume (% total brain volume). Considering regional differences, the most affected 295 region was the cortex, which was increased by 7.5% with a false discovery rate (FDR) of 1%. 296 MRI revealed significant increases in absolute regional volume of cerebral cortex, amygdala, and hippocampus (****p < 0.0001) in Chd8 +/mice. N: WT=21, Chd8 +/-=18. See Table S11 for full regional statistical analysis and FDR values. B. Increases in volume are still significant for the cortex (**p = 0.0097), amygdala (**p = 0.0014) and hippocampus (***p = 0.0004) after correction for absolute brain volume. (Student's t test p-value, error bars denote SEM). C. Increased cortical thickness is present in Chd8 +/mice. D. Voxel-wise differences in volume between Chd8 +/and WT littermates. at 5.4% (FDR of 3%) and 6.1% (FDR of 2%), respectively. When the male and female mice 298 were examined independently, female Chd8 +/mice exhibited stronger effect sizes but both sexes 299 exhibited overall similar trends. In addition to the summary regions, 159 independent brain 300 regions were assessed with divisions across the cortex, subcortical areas, and cerebellum. Full 301 results for comparison across individual brain regions are reported in Table S11 . Chd8 +/mice 302 showed robust increase in absolute volume across cortical regions, hippocampus (+10.3%, FDR 303 < 1%), and amygdala (+11.0%, FDR < 1%) ( Figure 5A-5B ). The Chd8 +/mice also displayed 304 increased cortical thickness, particularly along the cingulate cortex ( Figure 5C ). After correction 305 for total volume, relative volumes were still significantly larger, though cortex failed to surpass 306 the FDR < 5% cutoff. Deep cerebellar nuclei showed decreased relative volume (-1-3%, FDR < 307 2%). Voxel-wise differences showed similar trends ( Figure 5D ). Diffusion Tensor Imaging 308 (DTI) revealed no differences in fractional anisotropy or mean diffusivity in either the regional 309 or voxel-wise measurements, indicating that the anatomical connectivity of the white matter in 310 the Chd8 +/mice was not significantly different from WT littermates (not shown). 311
Behavioral phenotyping of adult Chd8 +/mice 312
Behaviors relevant to ASD were assessed in adult Chd8 +/mice using two assays of social 313 behaviors and two assays of repetitive behaviors (Figure 7) , as previously described 27 . In the 3-314 chambered social approach test 28 , normal sociability was detected in both genotypes ( Figure 7A female reciprocal social interaction test, in which male WT and Chd8 +/subject mice were 328 individually paired with an unfamiliar estrous B6 female ( Figure 7D-7E ). WT and Chd8 +/males 329 spent similar amounts of time engaged in sniffing ( Figure 7D; t (1, 17) = 0.35), and following 330 ( Figure 7E; t (1, 17) Our experiments confirm that Chd8 regulates proliferation and neurogenesis, and suggest 359 substantial impact across neurodevelopment. They also suggest similar binding targets and 360 biological function in mouse and human neurodevelopment and a parallel causal role of CHD8 361 haploinsufficiency in megalencephaly. We observed significant overlap between down-regulated 362 genes in Chd8 +/mice and autism risk gene sets produced by independent groups using a variety 363 of approaches 13, [16] [17] [18] . This overlap suggests that perturbation to neurodevelopment in Chd8 +/-364 mice parallels autism-relevant human neurobiology, a finding consistent with our 365 neuroanatomical and structural MRI results. 366
Our RNA analysis captures subtle changes in transcription across brain development in 367
Chd8 +/mice. These changes were consistent across developmental stages for perturbed genes, 368
were highly relevant to ASD-associated networks, and strongly correlated with biological 369 pathways and expression modules of interest. Our results parallel in vitro findings that suggested 370 convergence across risk pathways after CHD8 knockdown 12 , providing a developmental 371 framework revealing disruption of convergent ASD pathways in a genetic mouse model of Chd8 372 network analysis using in vivo data enabled characterization of the impact of Chd8 374 haploinsufficiency across neurodevelopment. 375
Our results suggest a developmental hierarchy of changes in Chd8 +/brain development. 376 in RNA processing, our results further indicate that disruption to RNA processing is an important 386 player in neurodevelopmental disorders, in line with other neurodevelopmental disorder genetic 387 models such as Fmr1 31 and Rbfox1 32 . Furthermore, though alternative splicing has been well-388 established to a critical role in cell differentiation and proliferation in the developing brain 33 , the 389 roles of other RNA processing pathways such as RNA stability or translocation in brain 390 development are less studied 34 and could provide potential candidates for future investigation. 391
While dysregulation of genes in M.1 and of RNA processing genes peaks at E17.5, our 392 analysis suggests changes across neurodevelopment driven by Chd8 haploinsufficiency. These 393 changes indicate convergent neuropathology connecting chromatin remodeling, neuronal 394 differentiation, and synaptic pathways, the principle gene networks identified in autism case 395 sequencing studies. For example, we observed down-regulation of genes involved in RNA 396 processing (e.g. Upf3b and Hnrnpd), neuronal differentiation (e.g. Bcl11a and Tbr1) and in 397 synapse development and function (e.g. Scn2a1 and Cacna1b), all of which have been implicated 398 in autism via human genetic studies. The transcription data generated for this study will be a 399 useful resource for future dissection of pathways involved in the pathogenesis of 400 neurodevelopmental disorders and in classification of risk genes from genetic studies. Further 401 studies may capture the neuroanatomical and cellular changes and perturbed signaling pathways 402 associated with differential expression signatures in Chd8 +/brain development. Future work will 403 also be necessary to determine the stage-and cell-specific role of Chd8-binding to establish and 404 maintain expression patterns of these genes. 405
Structural changes in the brain of adult Chd8 +/mice parallel other relevant mouse 406 models. A recent study examined 26 different mouse models related to autism 35 , clustering these 407 models into 3 distinct groups. Key aspects of Group 1 included larger sizes of cortical structures, 408 particularly the frontal and parietal lobes, and smaller sizes in the cerebellum, which is in line 409 with the Chd8 +/mouse described here. This group of models included Nrxn1α, Shank3, En2, and 410
Fmr1. The Chd8 +/mouse most resembled the differences found in the Fmr1 mutant mice. 411 In comparison to the Chd8 +/mice studied here, heterozygous mouse models of Pten, 417
another gene associated with ASD and macrocephaly, do exhibit core aspects of ASD 38 . 418 behavioral phenotypes with face value to ASD. Additional studies are necessary to further 420 examine behavioral phenotypes at earlier developmental stages to test for causal relationship 421 between structural changes and behavior in Chd8 +/mice. The presence of genomic and 422 neuroanatomical phenotypes in Chd8 +/mice that parallel the clinical signature of human CHD8 423 mutations suggests similar neurodevelopmental pathology between human and mouse. 424
Intriguingly normal phenotypes on the autism-relevant social and repetitive assays conducted 425 here highlight future opportunities for comprehensive behavioral phenotyping in a replication 426 cohort, to evaluate social and repetitive behaviors at juvenile ages and to investigate phenotypes 427 relevant to other symptom domains described for individuals with CHD8 mutations, including 428 cognitive impairments and attentional disorders. 429
Our initial survey of mice heterozygous for mutation to Chd8 revealed significant 430 findings across genomic and anatomical axes of neurobiology. These experiments link increased 431 regional brain volume to perturbations of biological pathways across neurodevelopment, 432 recapitulating primary neuroanatomical traits observed in CHD8 +/human individuals. As such, 433 the results offer insight into the neurodevelopmental pathology associated with mutations to 434 CHD8, a genetic model that appears to be a bellwether for mutations affecting early 435 transcriptional regulation and chromatin remodeling in autism. In-depth analysis of 436 developmental neuroanatomy and social and communicative phenotypes as well as associated 437 attentional and cognitive deficits in these Chd8 +/mice will be necessary to link observed 438 changes in brain gene expression and structure with relevant pathology in humans. This study of 439 the impact of Chd8 haploinsufficiency in vivo in mice demonstrates the power of genomic and 440
Generation of Chd8 mutant mice 445
We used Cas9-mediated mutagenesis of C56BL/6N oocytes to generate two mouse lines 446 harboring frameshift deletions (5 bp and 14 bp) in mouse Chd8 exon 5 (gRNA sequence: 447 GAGGAGGAGGTCGATGTAAC). Guide RNA was synthesized and pooled with Cas9 448 mRNA 39 and injected into mouse oocytes. We identified F0 pups carrying 5 bp and 14 bp 449 deletions that overlap the target sequence. Heterozygotes were crossed to WT C57BL/6N mice to 450 expand the lines and eliminate off-target mutations. We examined Chd8 protein and transcript 451 levels via western blot (ab114126; Abcam) and qPCR at E14.5, P0, and adult forebrain and 452 compared cortical length in whole mount P0 brains from Chd8 +/mice and matched WT 453 littermates. All mouse studies were approved by the Institutional Animal Care and Use 454
Committees at the University of California Davis and the Lawrence Berkeley National 455
Laboratory. Subject mice were housed in a temperature-controlled vivarium maintained on a 12 456 hour light-dark cycle. Efforts were made to minimize pain and distress and the number of 457 animals used. 458
Developmental neuroanatomy 459
Litters for neuroanatomy analysis were generated by breeding male Chd8 +/mice with 460 WT females. Brains were perfused before isolation, embedding, and sectioning. P7 Nissl 461 hours, females were anesthetized and embryos were perfused, fixed, and sectioned. EdU The slides were rinsed and incubated overnight at 4°C in fluorophore-conjugated secondary 470 antibodies. Slides were counterstained for 2 hr in DAPI, rinsed, and mounted. All sections over 471 the entire brain were surveyed for lamination defects and corresponding sections imaged. Within 472 each genotype, all brains were selected randomly for histological processing without taking 473 morphological criteria into account. All histology was done blind, by investigators that were 474 unaware of group allocation. No data points were excluded. All antibodies used for this study 475 were validated and their use widely reported. 476
Genomics 477
Bulk forebrain was microdissected from Chd8 +/and matched WT littermates at E12.5, 478 E14.5, E17.5, P0, and from adults (>P56). Samples included males and females of each genotype 479 at each stage. Total RNA was isolated using Ambion RNAqueous and assayed using an Agilent 480 BioAnalyzer instrument. Stranded mRNA sequencing libraries were prepared using TruSeq 481
Stranded mRNA kits and 6-12 samples per lane were pooled and sequenced on the Illumina 482
HiSeq platform using a single end 50 bp (E145, E17.5, P0, adult) or paired end 100 bp (E12.5) 483 strategy. FASTQ files were aligned to the mouse genome (mm9) and counts for mouse genes 484 discrete gene expression networks were identified (numbered by module gene count), and genes 490 that were not classified into one of these modules were assigned to M.8.grey. Permutation testing 491 was performed to test for overlap between DE genes and published gene sets. Gene Ontology 492
Biological Process term enrichment and protein-protein interaction network analysis was 493 performed using the TopGO Bioconductor package and STRING 26 . Differential expression of 494 selected targets was verified by qPCR at P0. Primers reported in Table S3 . For qPCR analysis, 9 495 wild-type and 7 Chd8 +/forebrain samples were used. Samples were excluded if technical 496 replicates failed. Paired t-test was performed on Actb normalized relative gene expression 497 between WT and Chd8 +/using ∆∆CT. To reduce noise, the highest and lowest values from both 498 groups was discarded. Tbr1 protein level assayed via western blot (ab31940; Abcam) compared 499 via Student's t-test. 500
MRI 501
After perfusion, brains from mice that underwent behavioral screening were scanned 502 using a multi-channel 7.0 Tesla MRI scanner (Varian Inc., Palo Alto, CA). Diffusion Tensor 503 Imaging (DTI) was done using a 3D diffusion weighted fast spin echo sequence to create 504 fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity maps for brains 505 used in this study. After registration, changes and intensity differences were examined for the 506 volume or mean diffusion measure for 159 different structures encompassing cortical lobes, large 507 summary regions were examined, including the cerebral cortex, olfactory bulbs, cerebral white 509 matter, cerebral gray matter, ventricles, brainstem, and cerebellum 41 . Multiple comparisons in 510 this study were controlled for via False Discovery Rate. 511
Behavioral testing 512
All procedures were approved by the University of California Davis Institutional Animal 513
Care and Use Committee, and were conducted in accordance with the National Institutes of 514
Health Guide for the Care and Use of Laboratory Animals. Efforts were made to minimize pain 515 and distress and the number of animals used. No previous analyses were performed on animals 516 used for behavioral testing. Subject mice were housed in a temperature-controlled vivarium 517 maintained on a 12 hour light-dark cycle. We used mixed genotype home cages with 2-4 animals 518 per cage and blinded experimenter and video scorer/processor to genotype during testing and 519 analysis. All tests were conducted during the light cycle. Groups sizes indicated are based on 520 past experience and power analyses. Effects of genotype and sex evaluated using Multi-factor 521 ANOVA, as previously published. Significant ANOVAs followed with Tukey's high significant 522
difference test, or other appropriate post hoc tests including Bonferroni correction tests for 523 multiple comparisons, to correct for false discovery and to identify specific differences between 524 groups. Behavioral analysis passed distribution normality tests, was collected using continuous 525 variables and thus analyzed via parametric analysis, in all assays. For all behavioral analyses, 526 variances were similar between groups and no data points were excluded. One animal died 527 during behavioral testing. This happened during Three Chamber Social approach, in the middle 528 of the behavioral battery. Chd8 +/male and female mice and WT littermates, ages 2-5 months, 529
were evaluated in a standard battery of neurobehavioral assays relevant to diagnostic symptoms 530 of autism 27 . In total, 8 male and 10 female Chd8 +/mice and 11 male and 10 female matched WT 531 littermates were tested in the following sequence: open field, general health, self-grooming, 532 marble burying, 3-chambered social approach, and male-female social interactions. Testing was 533 performed at the UC Davis MIND Institute Intellectual and Developmental Disabilities Research 534
Center Mouse Behavior Core. Statistical testing was performed using established assay-specific 535 methods, including Students t-test for single parameter comparisons between genotypes, and 536
One-Way or Two-Way Repeated Measures Analysis of Variance for comparisons across time 537 points and/or between sexes. 538
Data availability 539
All relevant data will be available from authors. DOIs for all published gene sets used in 540 
Code availability 546
All custom scripts used for data processing and analysis will be available from authors. A 547 custom sample processing pipeline was used to align raw sequencing samples to mouse genome 548 mm9 using RNA-seq aligner STAR (version 2.4.2a), features assigned via subreads 549 featureCounts (version 1.5.0) to UCSC mm9 genes.gtf, and quality check performed on 550 individual samples using RSeQC (version 2.6.3). Differential expression analysis was done with 551 a custom pipeline in R Studio using functions from edgeR (version 3.10.5) and limma (version 552 network analysis was performed with a custom pipeline following the standard WGCNA 554 
